Metabolic control analysis in drug discovery and disease

Nature Biotechnology

Volumn 20, Issue 3, 2002, Pages 243-249

  Cascante, Marta ^a   Boros, Laszlo G ^b   Comin Anduix, Begoña ^a   De Atauri, Pedro ^a   Centelles, Josep J ^a   Lee, Paul W N ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; DISEASES; DRUG PRODUCTS; ENZYMES; SUBSTRATES; TUMORS; VACCINES;

METABOLIC CONTROL ANALYSIS;

METABOLISM;

ANEUPLOIDY; CANCER; CANCER THERAPY; CELL METABOLISM; DIABETES MELLITUS; DRUG DEVELOPMENT; GENE DOSAGE; GENE FUNCTION; GENOMICS; GENOTYPE; METABOLIC DISORDER; METABOLIC REGULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SILENT GENE;

ANEUPLOIDY; ANIMALS; CELL DIVISION; CYANATES; DRUG INDUSTRY; GENETICS; GENOTYPE; HUMANS; NEOPLASMS; PARASITIC DISEASES; PHENOTYPE; PROTEINS; RATS;

EID: 0036195958     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0302-243     Document Type: Review

References (70)

1. Complexity in biological signaling systems
2. Genomic biology
3. Array of hope
4. Functional genomics: It's all how you read it
5. Protein function in the post-genomic era
6. Detection of elementary flux modes in biochemical networks: A promising tool for pathway analysis and metabolic engineering
7. Oncogenic alterations of metabolism
8. On the control of gene expression
9. From genome to cellular phenotype - A role for metabolic flux analysis?
10. Reflections on the scope and the future of metabolic engineering and its connections to functional genomics and drug discovery
11. Network rigidity and metabolic engineering in metabolite overproduction
12. Kinetics of multi-enzyme systems
13. Lessons from metabolic engineering for functional genomics and drug discovery
14. Metabolic engineering-methodologies and future prospects
15. Metabolic engineering: Techniques for analysis of targets for genetic manipulations
16. Tissue variation in the control of oxidative phosphorylation: Implication for mitochondrial diseases
17. Prospects for pharmacological manipulation of metabolism
18. Metabolic control
19. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations
20. Complex networks of interactions connect genes to phenotypes
21. From DNA sequence to biological function
22. Metabolic control analysis as a tool in the elucidation of the function of novel genes
23. Taking enzyme kinetics out of control; putting control into regulation
24. Co-response analysis: A new experimental strategy for metabolic control analysis
25. Composite control of cell function: Metabolic pathways behaving as single control units
26. How to recognize monofunctional units in a metabolic system
27. Functional genomics. Silent genes given voice
28. What do mitochondrial diseases teach us about normal mitochondrial functions that we already knew: Threshold expression of mitochondrial defects
29. The physiological role of glucokinase binding and translocation in hepatocytes
30. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
31. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
32. Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis
33. The molecular basis of dominance
34. Hereditary triosephosphate isomerase (TPI) deficiency: Two severely affected brothers, one with and one without neurological symptoms
35. Triosephosphate isomerase deficiency: Predictions and facts
36. Use of mathematical models for predicting the metabolic effect of large-scale enzyme activity alterations. Application to enzyme deficiencies of red blood cells
37. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
38. Ueber asymmetrische zellteilung in epithelkrebsen und deren biologische bedeutung
39. How aneuploidy affects metabolic control and causes cancer
40. On the origin of cancer cells
41. The unitarian or trophoblastic thesis of cancer
42. Pathways of carbohydrate metabolism and their physiological significance
43. Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: Validation in preclinical studies
44. Myocardial oxidative metabolism in hyperthyroid patients assessed by PET with carbon-11-acetate
45. The applications of PET in clinical oncology
46. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer
47. Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation
48. 2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells
49. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation
50. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study
51. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle
52. Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells
53. Genistein inhibits nonoxidativa ribose synthesis in MIA pancreatic adenocarcinoma cells: A new mechanism of controlling tumor growth
54. Glycolysis in bloodstream form Trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes
55. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness
56. What controls glycolysis in bloodstream form Trypanosoma brucel?
57. Compartmentation of glycolysis in trypanosomes: A potential target for new trypanocidal drugs
58. Metabolic control analysis of glycolysis in Trypanosomes as an approach to improve selectivity and effectiveness of drugs
59. Computer simulation as a tool for studying metabolism and drug design
60. How many phenotypes from one genotype? The case of Prion diseases